Ebitda Cambiamento Data
AbbVie USD 6.75B 433M 2023-09
Aceragen USD -7440000 1.14M 2023-03
Adma Biologics USD 16.34M 5.56M 2023-12
Amgen USD 3.66B 713M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Dynavax Technologies USD -5891000 12.02M 2023-12
Gilead Sciences USD 2.73B 579M 2023-12
Merck USD 7.51B 11.02B 2023-09
Minerva Neurosciences USD -6071000 1.56M 2023-09
Nektar Therapeutics USD -31809000 70K 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD -9914000 112.81M 2023-09
TG Therapeutics USD 114.86M 159.5M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Dynavax Technologies - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.